SARRAZIN, C. Dynamic hepatitis C virus genootupic and phenotypic changes in patients treated with the protease inhibitor telaprevir. Gastroenterology. 2007, 132, 1270-1278
KIEFFER, TL. Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients. Hepatology. 2007, 46, 631-639